Abstract:Objective: Marrow stromal cells (MSCs) have the potential to migrate toward sites of injury or disease in the central nervous system. Encouraging results have been obtained by using MSCs to deliver therapeutic molecules. However, most brain tumor animal models--unlike in actual human disease states--use cells with limited invasion properties. In the present study, C57/B16 mice were implanted with the highly invasive Ast11.9-2 glioma cell line to investigate the potential therapeutic effects of interleukin-12 (IL-12)-secreting MSCs. Methods: MSCs were infected with adenovirus encoding murine IL-12 (AdIL12). The infection conditions were optimized by determination of cytotoxicity and IL-12 secretion after AdIL12 infection in vitro. After implanting Ast11.9-2 tumor into mouse brain, we conducted a survival experiment to compare 4 distinct treatment groups by injecting culture medium control (sham), MSCs alone, MSCs infected with control virus (MSC-adenovirus encoding green fluorescent protein), and MSCs infected with IL-12-expressing virus (MSC-AdIL12) in the peritumoral region of the brain. Tumor tissues were analyzed by hematoxylin and eosin staining. IL-12 expression was analyzed by immunohistochemistry staining. Y chromosome fluorescent in situ hybridization was used to detect injected MSCs. Cell populations of CD57 (natural killer cells), CD3 (total T cells), and 7-AAD (dead cells) in whole brain tissue were analyzed by fluorescence-activated cell sorting at days 4 and 7 after therapeutic treatment. Results: Serum IL-12 increased significantly at days 4 and 7 after MSC-AdIL12 implantation. IL-12-expressing cells were detected by immunohistochemistry staining and Y chromosome-positive staining cells were found in the tumor area, confirming successful IL-12 delivery. MSC-AdIL12 treatment yielded increased natural killer cell infiltration in brain tissue at day 4, leading to an expected increase in nonspecific cell death, while total T-cell counts remained unchanged. MSC-IL-12 treatment extended animal survival but did not result in a statistically significant difference in comparison to other groups. Because all animals ultimately died of the brain tumors, MSC-AdIL12 treatment did not completely arrest the invasive growth pattern of these lesions. Conclusion: The results indicate that MSCs may serve as useful delivery vehicles for IL-12 and other antineoplastic agents in brain tumor therapy.

Functional Changes of Dendritic Cells in C6 Glioma-Bearing Rats That Underwent Combined Argon-Helium Cryotherapy and IL-12 Treatment

Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas

An Experimental Study of Vaccines for Treatment in Intracranial Gliomas by Dendritic Cells Pulsed with Apoptotic Tumor Cells

Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes.

Immunotherapy of Intracranial G422 Glioblastoma with Dendritic Cells Pulsed with Tumor Extract or RNA

Establishment of C6 Brain Glioma Models Through Stereotactic Technique for Laser Interstitial Thermotherapy Research

Immunotherapy of Rat Glioma Without Accumulation of Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells

An Experimental Study of Dendritic Cell-Based Vaccine Therapy for Intracranial Gliomas

Combined Ad-rhTNF-α Gene Therapy and Radiotherapy——Study in a C6/ Subcutaneous Malignant Glioma Model of Wistar Rat

The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model

Efficacy of argon-helium cryoablation combined with chemotherapy in the treatment of advanced NSCLC

Neoantigen-specific CD4+ T-cell Response is Critical for the Therapeutic Efficacy of Cryo-Thermal Therapy

Hyperthermia with different temperatures inhibits proliferation and promotes apoptosis through the EGFR/STAT3 pathway in C6 rat glioma cells

Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer

Dendritic Cells Loaded With Heat Shock Inactivated Glioma Stem Cells Enhance Antitumor Response of Mouse Glioma When Combining With CD47 Blockade

Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model

Specific T Cell Immunotherapy Against Glioblastoma with Mouse Model

The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response

Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model

Cryo-thermal Therapy Inducing MI Macrophage Polarization Created CXCL10 and IL-6-rich Pro-Inflammatory Environment for CD4+ T Cell-Mediated Anti-Tumor Immunity.

Interleukin-6 Induced “Acute” Phenotypic Microenvironment Promotes Th1 Anti-Tumor Immunity in Cryo-Thermal Therapy Revealed By Shotgun and Parallel Reaction Monitoring Proteomics